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Abstract. Diffuse correlation spectroscopy (DCS) measurements in vivo recorded from rabbits’ ocular fundus are
presented. Despite the complexity of these ocular tissues, we provide a clear and simple demonstration of the DCS
abilities to analyze variations in physiological quantities of clinical interest. Indeed, the reported experimental activ-
ities demonstrate that DCS can reveal both choroidal-flow and temperature variations and detect nano- and micro-
aggregates in ocular fundus circulation. Such abilities can be of great interest both in fundamental research and
practical clinical applications. The proposed measuring system can be useful in: (a) monitoring choroidal blood
flow variations, (b) determining the end-point for photo-dynamic therapy and transpupillary thermo therapy and,
(c) managing the dye injection and determining an end-point for dye-enhanced photothrombosis. Moreover, it
could allow both diagnoses when the presence of nano- and micro-aggregates is related to specific diseases
and verifying the effects of nanoparticle injection in nanomedicine. Even though the reported results demonstrate
the applicability of DCS to investigate ocular fundus, a detailed and accurate investigation of the limits of detection
is beyond the scope of this article. © 2013 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.18.5.057001]
Keywords: ophthalmology; optical devices; ocular blood flow; photo-dynamic therapy; transpupillary thermo therapy; dye-enhanced
photothrombosis; nanoparticles; nanomedicine.
Paper 12372RRR received Jun. 13, 2012; revised manuscript received Mar. 29, 2013; accepted for publication Apr. 4, 2013; published
online May 2, 2013.
1 Introduction
This paper is aimed at reporting and reviewing our current and
past research activities focused on the ocular fundus optical
inspection performed by using diffuse correlation spectroscopy
(DCS).
DCS is a technique able to reveal microscopic movement in
turbid media such as complex fluid and biological tissues.1–3
Thanks to its noninvasiveness, portability, and high temporal
resolution, DCS technique could be of great interest both in
fundamental research and practical applications in medicine
and biology. Nevertheless, to the best of our knowledge, our
previous papers4–7 were the first and only studies reporting
DCS-measurements in vivo recorded from the ocular tissues.
This apparent lack of interest in analyzing the eye by using DCS
is probably mainly due to the difficulties in accessing the
posterior segment. Actually, although noncontact DCS measur-
ing systems have been already reported in literature,8–11 the
peculiar optics of the eyes is such that probably none of the
above-cited systems has adequate optics to perform DCS ocular
measurements. Nevertheless, the transparency of eye permits a
more accurate noninvasive optical inspection of the human
vasculature than in any other tissue; ocular fundus with its capil-
lary bed represents a unique tissue in the human body. These
aspects are well known from the early experiments performed
in 1972 by Riva et al.12 using the technique of laser Doppler
velocimetry to investigate the retinal blood flow. Currently,
various optical instruments are commonly used in ophthalmic
practice to diagnose eye circulation pathologies and to perform
medical treatments; we believe that DCS could be effectively
integrated into this type of instrumentation.
Ocular fundus is known to be a thin-layered complex
scattering and absorbing medium13 where semi-infinite and
homogeneous medium approximations are not satisfied and
neither single-scattering regime nor multiple-scattering regime
are applicable.4,6 This is probably another reason why few
ocular fundus investigations based on coherent light sources
have been so far reported in literature (excluding Doppler
measurements).
Despite the complexity of the measurand, our previous works
showed that DCS analysis of the ocular fundus can both reveal
blood flow and temperature variations,4–6 and detect nano- and
micro-aggregates in ocular fundus blood flow.7
Nevertheless, the analytical description of the intensity
autocorrelation function originating from the radiation diffused
by the ocular fundus is considerably problematic; thus our pre-
vious data analysis methods involved specialized theoretical
models focused on the investigation of specific quantities of
interest—temperature, flow, or nano- and micro-aggregates.
In this paper we would like to provide a more simple yet
robust approach that by giving up specific models, provides
an intuitive and “pictorial” description of DCS capabilities to
investigate the ocular fundus. Such simplified data analysis
method is not intended to replace the previous specialized data
analysis methods,4–6 but to provide a flexible approach useful
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for simplified analysis and able to readily manage a wide range
of clinical situations.
In particular, our attention will be focused on the abilities to
reveal choroidal blood flow (ChBF) and temperature variations,
and to detect nano- and micro-aggregates in ocular fundus
circulation.
The study of the ocular hemodynamic allows earlier disease
detection, differentiation, and new treatment possibilities. In
particular, ChBF plays an important role in the progression
of a number of ophthalmic diseases, including glaucoma, age-
related macular degeneration, and diabetic retinopathy.
Laser Doppler and DCS are based on the same physical prin-
ciple and offer the advantage to provide noninvasive mea-
surements of blood flow even without the need for exogenous
tracers. However, although commercial laser Doppler ocular
flowmeters are both single-point (e.g., Oculix, Switzerland)
and imaging monitors (e.g., Heidelberg Retinal Flowmeter,
Germany), they perform the Doppler measurements using
confocal configurations, and therefore the volume probed by
the detected photons is accordingly small. On the contrary, in
DCS the source—illumination—and the detection regions are
not overlapped thus allowing the inspection of deeper choroidal
vessels exploiting the analysis of the temporal intensity fluctu-
ations of multiply scattered light.14 Moreover, single photon
counting approach of DCS offers better performance in terms
of sensitivity; hence allowing to better investigate the feeble
signal arising from multiple-scattering.
The ability to reveal blood flow and temperature variations
and to detect nano- and micro-aggregates in ocular fundus can
be of great interest both in fundamental research and practical
clinical applications.
As an example, the ability to reveal blood flow and
temperature variations can be useful in determining an end-
point for photo dynamic therapy (PDT) and transpupillary
thermo therapy (TTT). According to Schule et al.,15 “Especially
for TTT, a purely thermal treatment modality, the inter- and
intra-individual variability of the ocular transmission, retinal
absorption, and choroidal blood perfusion makes a treatment
outcome nearly unpredictable.” Actually, two techniques have
been proposed to monitor the laser-induced retinal temperature
increase: (a) the analysis of the fluorescent content released
by thermosensitive liposome-encapsulated dye once they are
heated above their threshold temperature,16,17 and (b) the opto-
acoustic analysis of the thermal expansion of the retinal pigment
epithelium (RPE).18 Also (static) light scattering spectroscopy
has been proposed to study the thermal effects arising during
PDT and TTT laser treatments.15,19 However, neither of the
above-cited techniques have been able to reach clinical maturity,
thus according to Fuisting and Richard,20 no measurement
method is available to determine an objective end-point for
the treatment; hence under-treatment (persistence of pathology)
as well as over-treatment (inducing a retinal scar—local blind-
ing—6% to 10% of patients) are possible.20,21
Detection of nano- and micro-aggregates in ocular fundus
circulation potentially allows both diagnoses when the pres-
ence of such aggregates is related to specific diseases, i.e.,
diseases related to the environmental pollution,22–24 and verify
for instance the diffusion of nanoparticles (NPs) injection in
nanomedicine.25,26
Nano- and micro-particles play an increasingly important
role in medical research, e.g., as drug delivery vehicles27,28 and
contrast/therapeutic agents.29–31 As an example, they are used
experimentally for numerous in vivo applications such as mag-
netic resonance imaging contrast enhancement, tissue repair,
immunoassay, detoxification of biological fluids, hyperthermia,
and cell separation. However, the physiology of the dispersion
of such nano- and or micro-particles inside the human body is
quite complex and not easily predictable,32–34 since it depends
on the nano- micro-particles surface and coating characteristics
and on their interactions with the blood components and the
complexes they can generate.
The abilities to detect nano- andmicro-aggregates and tomon-
itor the fundus temperature could be also useful in dye-enhanced
photothrombosis (DEP). The DEP is a photothrombotic therapy
that uses absorbing dye injected intravenously in order to enhance
the absorption of the laser radiation, thus allowing to reduce
power and/or duration of the laser treatment hence potentially
reducing photothrombosis side effects. However, DEP is
known to be prone to produce thrombi in the vessels.35–38
Information that can be obtained with DCS could help to
properly modulate dye injection flow rate and dose, thus poten-
tially allowing to reduce thrombi in the fundus vessels. As well
as for TTT, the ability to monitor blood flow and temperature
variations can be useful in determining the end-point for the
DEP treatment, hence minimizing side effects due to the laser
radiation.
As it will be discussed in Sec. 4.6, also optical coherence
tomography (OCT) has been already demonstrated to be able
to investigate retinal and ChBF and to detect NPs in biological
tissues. Many commercial OCT systems exist so their additional
complexity and cost are not necessarily a problem for clinical
use; however DCS cost is lower as it is a point measurement
technique, not an imaging technique. Therefore, the proposed
measuring system could be a good alternative for applications
where imaging is not needed. Moreover, to the best of our
knowledge, no study reports about the ability of OCT in deter-
mining the end-point for TTT treatments.
In order to in vivo test the performance of DCS technique,
three measurement activities have been performed on the ocular
fundus of animal models: (a) analysis of the variation of the
ChBF, (b) analysis of the moderate temperature increase pro-
duced by a gentle TTT treatment, and (c) analysis of the transit
of Au-nanoparticles (Au-NPs) injected in a vein. The obtained
results suggest that DCS can allow to measure flow and tem-
perature variation and detect nano- and micro-aggregates in the
ocular blood flow.
In the following sections, Sec. 2 provides a concise overview
of the theoretical background (Sec. 2.1), describes the developed
measuring instrument (Sec. 2.2), the developed data analysis
method (Sec. 2.3), the performed tests (Sec. 2.4), and the meas-
urement procedure (Sec. 2.5). The obtained results are reported
in Sec. 3 and discussion and conclusions are drawn in Sec. 4.
2 Materials and Methods
2.1 Theoretical Background
The DCS falls into dynamic light scattering (DLS) techniques.
The DLS relay on dielectric constant ε fluctuations inside the
sample volume—scatterers—and it analyzes the temporal fluc-
tuations of the collected optical intensity in order to infer infor-
mation about the scatterers dynamics.
The long history and the many applications of DLS tech-
nique led it to be referred by many different names. As an
example, frequently encountered names are dynamic light
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scattering itself (DLS), quasi-elastic light scattering, laser light
scattering, light mixing spectroscopy, and photon correlation
spectroscopy. Moreover, when the sample volume dimensions
are larger than the transport mean free path ls 0 , photons propa-
gation within the sample can be accurately described using
diffusion approximation.39 As a result, from the earlier papers
by Pine et al.,1,39 the analysis of such multiple-scattering regime
is known as diffusing wave spectroscopy (DWS). In biomedical
optics, DWS is generally referred as DCS.9–11,14
Data analysis is usually different for the intensity fluctuations
of light scattered only once (single-scattering regime) and for
the multiple-scattering regime.40 In general, the normalized elec-
tric-field autocorrelation function g1ðτÞ can be written as40
g1ðτÞ ¼
Z
∞
0
PðsÞ · gs1ðτÞds
¼
Z
∞
0
PðsÞ · exp

−
1
6
hq2ihΔr2ðτÞi s
ls

ds; (1)
where PðsÞ is the probability that the revealed photons traveled a
path of length s, gs1ðτÞ is the normalized elementary linear cor-
relation corresponding to a path of length s, hq2i is the mean
square of the scattering vector, hΔr2ðτÞi is the mean-squared
displacement of scattering sites after a time τ and, ls ¼ 1∕μs
is the mean distance between the scattering events.
In single-scattering regime, the photon paths probability den-
sity PðsÞ reduces to the Dirac’s Delta function and s∕ls ≈ 1, thus
g1ðτÞ depends on the scattering vector q set by the experimental
setup. As the number of experienced scattering events increases,
the PðsÞ deviates from the Dirac’s Delta function, hence the
effective momentum gradually transfers from q to the mean
square of the scattering vector hq2i.40
Photons propagation in ocular fundus is ruled by the scatter-
ing caused by inhomogeneities (scattering coefficient μs and
anisotropy g) and absorption in constituents (absorption coeffi-
cient μa). In particular, fundus optical properties and geometri-
cal dimensions are such to cause an intermediate regime, where
neither the single-scattering nor the diffusion approximations
can be applied.4,6 Indeed, the separation between the illumina-
tion and the collection locations set during experimental activ-
ities was such that photons propagation was almost still in the
transport regime, thus the name DCS has been chosen mainly
because of the use of photon counting detection.
According to Zakharov and Scheffold,40 such intermediate
regime represents the most difficult situation since no rigorous
theory can be applied and “theoretical modeling for this
complicated situation is very difficult and sample-dependent.”
Moreover, Eq. (1) is valid for homogeneous samples—samples
in which optical and dynamical properties are statistically the
same all over the sample—whereas ocular fundus is a layered
sample. As a result, our previous articles were based on specific
theoretical models focused on the analysis of a well-defined
quantity, i.e., flow, temperature or nano- and micro-aggregates.
Nevertheless, according to Eq. (1), it is easy to notice that the
g1ðτÞ function is influenced by both the scatterers motion
hΔr2ðτÞi and changes in the optical and/or morphological prop-
erties that leads to PðsÞ, hq2i and/or ls variations.
Scatterers in ocular fundus are both “semi-static”—
membranes, nuclei, mitochondria, pigment granules, and the
other biological structures moving under thermal agitation—
and “dynamic”—blood constituents, mainly red blood cells
(RBCs)—therefore their motion is mainly induced by thermal
agitation and blood flow. Hence, DCS is expected to be able
to detect variation in both temperature and/or blood flow.
Moreover, DCS technique is expected to be able to investi-
gate any quantity that gives rise to changes in any one of PðsÞ,
hq2i and, ls. Nano- and micro-aggregates carried by the blood
flow alter the fundus optical properties, thus giving rise to var-
iations in PðsÞ, hq2i and, ls, therefore DCS is supposed to be
able to detect them.
2.2 Measuring System
The developed instrument is based on a commercial ophthalmic
microscope (OM) (BQ900, Haag-Streit AG, Switzerland). As
shown in Fig. 1, a coherent beam (probe beam, PB) generated
by an He-Ne laser (model 1507-0, JDS Uniphase, USA—
emission wavelength of about 633 nm) is coupled to OM by
using: (a) the collimating lens L1 (LPSC-03-.633-4/125-S-40-
6°-11-1-3a-2, OZ Optics, Canada), (b) the single-mode optical
fiber OF1 (model SMJ-33-633-5/125-5AS-1, OZ Optics,
Canada), (c) the collimating lens L2 (LPSC-03-.633-4/125-S-
40-6°-11-1-3a-2, OZ Optics, Canada) and, (d) the custom made
beam splitter BS based on a 50/50 beam splitter (model
1002237, Haag-Streit AG, Switzerland) in which the BS-side
relative to the probe beam has been replaced by a mirror.6
The probe beam power at the output of the OM measured
in accordance with the measurement procedure reported in
IEC 60825-1:200141 is about 250 μW. Therefore, according
Fig. 1 Schematic cross-section of the developed measuring system. The
probe beam (PB, —) generated by the He-Ne is coupled to the oph-
thalmic microscope (OM) by using: the lens L1, the optical fiber
OF1, the lens L2 and, the beam splitter (BS). The back-diffused radiation
(collection beam CB, – – –) is collected by the OM optics and the
L3 lens, then guided by the optical fiber OF2. The interference optical
filter F allows only the He-Ne scattered light to pass. The single photon
counting (SPC) process the so-collected scattered light, then, the digital
correlator (DC) computes the intensity autocorrelation function. The
therapeutic laser system (TL, small gray circle) is fixed in front of
the slit lamp (SL, wider gray circle) and the therapeutic laser beam
(TLB,—) is aligned to the OM optical-axis by using the dichroic splitter
(DS, small purple rectangle in color version). The infrared optical filter
(IRF) avoids the TL radiation to reach ophthalmologist’s eyes during
transpupillary thermo therapy (TTT) treatments. The Goldmann laser-
coated contact lens (GCL) is aimed at both making fundus observation
easy and guiding the laser beams.
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to ISO 15004-2,42 no potential light hazard theoretically exists
when using the developed measuring system.
The collection of the signal diffused by the ocular fundus
(collection beam, CB) is performed by using: (a) OM, (b) BS,
(c) the collimating lens L3 (LPSC-03-.633-4/125-S-40-6°-11-1-
3a-2, OZ Optics, Canada), and (d) the single-mode optical fiber
OF2(model SMJ-33-633-5/125-5AS-1, OZ Optics, Canada).
To select only the He-Ne scattered light, the interference
filter F (FL05632.8-3, Thorlabs, USA) was fixed in front of
the collection lens L3.
The so-collected scattered light was guided to the single
photon counting module SPC (SPCM-AQR-14-FC, Perkin-
Elmer, Canada), then processed by the digital correlator DC
(FLEX-99S160B, Correlator.com, USA) to calculate the nor-
malized intensity autocorrelation function g2ðτÞ.
To test the ability to detect fundus temperature variations, the
OM was also equipped with a commercial therapeutic laser-
diode system therapeutic laser (TL) (IRIDIS 810 nm photo-
coagulator, Quantel Medical, France).
The laser beam (TLB—therapeutic-laser beam) generated by
the therapeutic laser (TL) was aligned to the OM optics by using
the custom-made dichroic splitter DS;6 the infrared optical filter
(IRF) avoids the TL radiation to reach ophthalmologist’s eyes
during TTT treatments. A diaphragm system allowed changing
the TLB spot diameter from 800 to 4100 μm. Irradiation time
and power were adjusted by using the TL controller.
A picture of the developed measuring system is shown
in Fig. 2.
As shown in Figs. 1 and 2, during experimental activities a
Goldmann laser-coated contact lens (GCL) was put on the rabbit
cornea to both make fundus observation easy and to guide the
laser beams.
2.3 Data Analysis
The standard approach in DLS technique is based on the
temporal correlation method, thus basing on a mathematical
framework able to describe the temporal field correlation func-
tion g1, i.e., Eq. (1). However, photodetectors are known to be
square-law detectors, thus providing an estimation of the optical
intensity autocorrelation function G2ðτÞ.
For ergodic systems, g1ðτÞ can be easily derived from G2ðτÞ
thanks to the Siegert equation.1,43 Unfortunately, scatterers
motion in biological tissues is generally restricted and/or the
sample dynamics is macroscopically heterogeneous, thus result-
ing in nonergodic systems. Moreover, due to the limited acquis-
ition time of in vivo experiments, also systems with ergodic
dynamics can demonstrate apparent nonergodic properties.
Nevertheless, thanks to the usage of a single-mode collection
fiber, and supposing the normalized electric field autocorrelation
function to be a real function, it is possible to easily estimate the
g1ðτÞ from the measured G2ðτÞ.4,44 As a result, useful informa-
tion can be easily extracted from the estimated g1ðτÞ functions
by determining the delay τX at which the g1ðτÞ equals a certain
value X.
In general, the higher the derivative of the g1ðτÞ function, the
lower the uncertainty in estimating the crossing condition
g1ðτXÞ ¼ τX. Preliminary empirical analysis of the recorded
g1ðτÞ revealed that the maximum derivative substantially
occurred at g1ðτÞ ≈ 0.5. Therefore, according to our previous
work,7 the obtained g1ðτÞ functions can be simply analyzed
by finding the “characteristic” decay time τ0.5 at which
g1ðτÞ ¼ 0.5:
τ0.5 ¼ τ∶g1ðτÞ ¼ 0.5: (2)
Given the quantization of decay times τi provided by the DC,
the τ0.5 can be readily estimated by performing a linear interpo-
lation of the experimental g1ðτÞ data, then finding the τ value
that satisfies the g1ðτÞ ¼ 0.5 condition:
if g1ðτiÞ ≥ 0.5 & &g1ðτiþ1Þ < 0.5
then τ0.5 ¼
τiþ1 − τi
g1ðτiÞ − g1ðτiþ1Þ
· ½g1ðτiÞ − 0.5 þ τi; (3)
where the symbol && refers to the Matlab syntax for logical
AND operation with short-circuiting behavior.
If the g1ðτÞ autocorrelation functions are too “noisy,” a
smooth function can be applied before using Eq. (3).
Regardless of the autocorrelation functions noise, according
to Eq. (1) the decay time τ0.5 depends on the optical and dynami-
cal properties of the investigated ocular region, thus the simple
τ0.5 data analysis method could be influenced by inter- and intra-
individual variability of the ocular transmission, retinal absorp-
tion, and choroidal blood perfusion. As a result, in this paper,
we also propose a new simplified data analysis method based
on the percentage variation Δτ0.5. The Δτ0.5 value relative to
the τ0.5 value is simply defined as
Δτ0.5 ¼
τ0.5 − τBASE
τBASE
· 100ð%Þ; (4)
where τBASE is the mean τ0.5 recorded during the baseline:
τBASE ¼
1
nBASE
·
XnBASE
i¼1
τ0.5−i; (5)
nBASE is the number of g1ðτÞ functions acquired during the
baseline and, τ0.5−i is the i’th τ0.5 recorded.
Due to the percentage variation analysis, the Δτ0.5 analysis
could be more robust to inter- and intra-individual variability
than the τ0.5 analysis.
Fig. 2 Picture of the developed measuring system.
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2.4 Experimental Activities: Performed Tests
The reported activities (Secs. 3.1–3.4) have been performed on
albino New Zealand rabbits.
The proposed experimental activities consisted in analyzing
the variation of τ0.5 and Δτ0.5 as a function of the applied stimu-
lus. Therefore, the measurement uncertainty relative to the
proposed measurement procedure can be roughly estimated
by analyzing the decay times τ0.5 and the percentage varia-
tions Δτ0.5 recorded under the same nominal conditions—no
stimulus—and calculating the related experimental standard
deviations of the sample σ. As a result, in measurement uncer-
tainty analysis nBASE equals the number of g1ðτÞ functions com-
posing the whole investigated dataset, thus τBASE is the mean
τ0.5. Hence,
σ ¼

1
nBASE − 1
·
XnBASE
i¼1
ðτ0.5−i − τBASEÞ2
1
2
: (6)
Since the variance V½ of a random variable X and a con-
stant k has the following properties V½X þ k ¼ V½X and
V½X · k ¼ V½X · k2, from Eq. (4), it is easy to notice that
the percentage standard deviations of the random variables
τ0.5 [σ% ¼ ðσ∕τBASEÞ · 100] equals the standard deviations of
the random variables Δτ0.5.
Conversely, to test the abilities to reveal blood flow and tem-
perature variations and to detect nano- and micro-aggregates in
ocular fundus circulation, three measurement activities have
been performed: (a) variation of the ChBF by increasing the
intra-ocular pressure (IOP), (b) moderate temperature increase
performed by using TL (Fig. 1) and, (c) injection of Au-NPs.
Preliminary activities have been performed collecting some
datasets from both eyes of two different animal models, thus
roughly investigating the DCS potential to detect the effects
due to increased IOP, TTT treatments, and NPs injections.
Then, in order to avoid any potential “cross-contamination”
issues, all the reported measurements have been obtained from
“intact animal models”—neither IOP increase nor TTT treat-
ment nor NPs injection was performed before acquiring the
reported measurements. As a result, the measurements reported
in Secs. 3.2–3.4 have been obtained from three different “intact”
animals models.
Measurements have been acquired from the inferior para-
papillary region, and given the interest in ChBF, the examined
retinal sites were chosen far away from visible retinal vessels.
A detailed description of the animal preparation, the instru-
ment setting and the measurement protocols is reported in
Sec. 2.5.
2.5 Animal Preparation, Instrument Setting, and
Measurement Protocols
As previously stated, the reported activities have been per-
formed on five male albino New Zealand rabbits bought at
Charles River Laboratories Italia Srl (Sant’Angelo Lodigiano,
Milan, Italy). Even though the system was previously demon-
strated on pigmented rabbits,4,5 in order to easily avoid any ocu-
lar damage during temperature elevation analysis and since the
interest in ChBF, albino rabbits have been preferred to pig-
mented rabbits because of their higher threshold power during
TTT45 and their rudimentary retinal circulation.46
2.5.1 Animal preparation: anesthesia and immobilization
technique
The rabbits were housed in the university animal facility, and
were given food and water ad libitum for at least one week prior
to the experiments. The animals were then treated according to
the guidelines and requirements of the ARVO convention for
animal experimentation ethics.
During experimental activities, the animals were anesthe-
tized through intramuscular injection of ketamine (30 mg∕kg)
and xilor (4 mg∕kg). Then, as shown in Fig. 2 the animal
under test was immobilized by using a guillotine system. The
performed sedation and the soft restriction of movement
imposed by the Goldmann contact lens substantially prevent
rabbit’s eye to move, thus no other mechanical tool besides
the guillotine system was used to immobilize the rabbit’s eye.
2.5.2 Instrument setting and description of the
measurement protocols
The OM magnification was set to 10×, then the distance
between the illumination spot and the collection point of the
scattered light at the OM focal plane was set to 2 mm.
According to our previous papers,4,6 such measurement geom-
etry reasonably allows to investigate all the ocular fundus
layers—from retina to sclera.
As previously stated, during the in vivo activities a GLC
(Fig. 1) was put on the rabbit cornea to make fundus observation
easy by the ophthalmologist and to guide the illumination beam
(probe beam, PB) and the collected scattered light (collection
beam, CB).
All the measurements have been performed at room temper-
ature and after 30 min warm-up time for the He-Ne laser, the
SPC and the DC.
2.5.3 Measurement uncertainty
Measurement uncertainty estimation has been performed by
recording the g1ðτÞ functions from five male albino New
Zealand rabbit (rabbit’s ages from about nine months to about
fifteen months and, rabbit’s weights from ≈3 to ≈5 kg). From
each of such animal models, g1ðτÞ functions have been acquired
from random ocular fundus regions without applying any stimu-
lus, thus estimating the τ0.5 and Δτ0.5 values according to
Eqs. (2) and (4).
2.5.4 Variation of the choroidal blood flow
It is known that ChBF can be readily changed by altering the
IOP.47 Therefore, the former activity investigates moderate
ischemia induced by applying an overpressure by using the
GCL (Fig. 1).
The reported measurements (Sec. 3.2) have been acquired
from a male albino New Zealand rabbit of about nine months
old and 3 kg weight.
Analyses have been performed by comparing the autocorre-
lation functions acquired before and during the ocular overpres-
sures. In particular, due to the variability of the handmade
overpressure, the measurement method consisted in acquiring
one autocorrelation function before (BðiÞ—baseline) and one
during the overpressure (DðiÞ); the acquisition time of each auto-
correlation function was 10 s. Figure 3 shows the timing dia-
gram of the performed GCL overpressure.
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2.5.5 Moderate temperature increase
The second activity investigates the moderate temperature varia-
tion due to the gentle heating generated by a “low-power” TTT
treatment. The TTT consists of an infrared laser radiation, which
mainly heats the chorioretinal layers (thanks to the great chorior-
etinal penetration of IR-light).
The reported measurements (Sec. 3.3) have been acquired
from a male albino New Zealand rabbit of about nine months
old and 3.5 kg weight.
Measurement method consisted in acquiring nine autocorre-
lation functions 10-s long [one before the treatment (baseline),
three during the treatment, and five after the treatment]. Table 1
reports the settings of the performed TTT treatment.
2.5.6 Injection of Au-nanoparticles
Finally, the ability to detect nano- and micro-aggregates has
been tested by injecting a bolus of Au-NPs and isotonic saline
solution in the ear vein of a rabbit. The reported measure-
ments (Sec. 3.4) have been acquired from a male albino
New Zealand rabbit of about nine months old and little less
than 3.5 kg weight.
Measurement method consisted in the acquisition of 4 auto-
correlation functions before starting NPs injection (Bð1Þ ÷ Bð4Þ)
(baseline), then, a Au-NPs bolus has been injected in the
marginal ear vein of the rabbit during the acquisition of two
autocorrelation functions (Dð1Þ ÷ Dð2Þ). Finally, 10 autocor-
relation functions have been acquired after the injection
(Að1Þ ÷ Að10Þ).
For all the acquired autocorrelation functions, the acquisition
time was set to 5 s. Actually, Au-NPs injection started during
the acquisition of the Dð1Þ autocorrelation function and ended
during the acquisition of the Dð2Þ autocorrelation function.
However, Au-NPs injection has been handmade, thus both the
injection timescale and, the Au-NPs injection flow rate were
affected by high uncertainty.
Data about the injected bolus are reported in Table 2.
3 Results
Experimental activities have been performed according to the
measurement procedures previously reported (Sec. 2.5). The fol-
lowing subsections report the results obtained in the experiments
aimed at testing the abilities to reveal ChBF and temperature
variations and to detect the transit of nano- and micro-aggregates
in ocular fundus.
3.1 Measurement Uncertainty
As previously stated, measurement uncertainty has been roughly
estimated from the analysis of the τ0.5 and Δτ0.5 recorded under
the same nominal conditions. Preliminary tests demonstrated
that regardless of the investigated animal model, measurement
duration tmeas—time required for the acquisition of the entire set
of measurements—exceeding 110 ÷ 120 s rapidly increases the
Fig. 3 Timing diagram indicative of the performed handmade overpres-
sure. The 10 s long baseline measurement (BðiÞ—overpressure = OFF) is
followed by the 10 s long measurement acquired during the overpres-
sure (DðiÞ—overpressure = ON).
Table 1 Settings of the performed transpupillary thermo therapy (TTT)
treatment.
Power 200 mW
Spot size (diameter) 4100 μm
Duration 30 s
Table 2 Specifications of the Au-nanoparticles (Au-NPs) bolus.
Composition Gold
Shape Spherical
Diameter 20 nm
Surface inorganic coating Citrate ions
Concentration (NPs molarity) 0.02 μM
Mass 0.1 mg∕ml
Solvent Sodium citrate 0.85 mM
pH 7
Overall injected volume (solvent and NPs) 0.2 ml
Fig. 4 Examples of characteristic decay times τ0.5 obtained under the
same nominal conditions. Void circles (◯) have been obtained with
an acquisition time of 5 s (τBASE ¼ 55 μs, experimental standard
deviation of the sample σ ¼ 1.0 μs and, percentage experimental stan-
dard deviation of the sample σ% ¼ 1.8%) whereas, filled circles (•)
have been obtained with an acquisition time of 10 s (τBASE ¼ 47 μs,
experimental standard deviation of the sample σ ¼ 3.0 μs and, percent-
age experimental standard deviation of the sample σ% ¼ 6%).
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measurement uncertainty. As a result, only sets of measurements
obtained with 40 s ≤ tmeas < 100 s have been taken into account
for the measurement uncertainty estimation.
All datasets obtained with 40 s ≤ tmeas < 100 s shown similar
behaviors. For all the analyzed datasets the jΔτ0:5j were usually
less than 8% and jΔτ0:5j greater than 10% have been seldom
encountered [as reported in Sec. 2.4, in measurement uncer-
tainty analysis nBASE equals the number of g1ðτÞ functions
composing the investigated dataset]. Therefore, the obtained
percentage experimental standard deviations of the sample
σ% ¼ ðσ∕τBASEÞ · 100, were essentially less than 8%.
Figure 4 shows an example of two sets of τ0.5 obtained under
the same nominal conditions—no external stimulus [no smooth
function has been performed on the recoded g1ðτÞ functions in
order to estimate the shown τ0.5]. Figure 5 shows the Δτ0.5
values relative to the τ0.5 shown in Fig. 4.
3.2 Variation of the Choroidal Blood Flow
The ability of DCS to detect variation in ChBF has been inves-
tigated by inducing moderate ischemia. As previously stated,
blood flow reductions have been obtained by applying an over-
pressure using the GCL. Figure 6 shows 5 (BðiÞ, DðiÞ) pairs of
the obtained autocorrelation functions. All the g1ðτÞ functions
shown in Fig. 6 have been obtained from the same rabbit
(see Sec. 2.5).
According to Sec. 2.3, the acquired measurements have been
investigated both in terms of characteristic decay times τ0.5 [see
Eq. (2)] and percentage variationsΔτ0.5 [see Eq. (4)] [no smooth
function has been performed on the recoded g1ðτÞ functions].
The obtained τ0.5 and Δτ0.5 are shown in Figs. 7 and 8,
respectively.
Fig. 5 Examples of percentage variation Δτ0.5 obtained under the same
nominal conditions. Void circles (◯) have been obtained with an
acquisition time of 5 s whereas, filled circles (•) have been obtained
with an acquisition time of 10 s.
Fig. 6 Autocorrelation functions pairs acquired during the activities
aimed at testing the ability to reveal choroidal blood flow (ChBF) var-
iations. For each of the five pairs of acquired autocorrelation functions,
the measurement acquired before the overpressure (BðiÞ) is drawn in
continuous line (—), whereas the measurement acquired during the
overpressure (DðiÞ) is drawn in dashed line (– – –). The horizontal
dashed-dot line (– . – . –) indicates the g1ðτÞ ¼ 0.5 condition of Eq. (2).
Fig. 7 Characteristic decay times τ0.5 relative to the five autocorrelation
functions pairs acquired during the activities aimed at testing the ability
to reveal ChBF variations (Fig. 6). For each pair, the τ0.5 recorded before
the overpressure (BðiÞ, i ∈ ½1; : : : ;5) is drawn with a circle (◯), whereas
the τ0.5 recorded during the overpressure (DðiÞ, i ∈ ½1; : : : ;5) is drawn
with a square (□).
Fig. 8 Percentage variation Δτ0.5 relative to the five autocorrelation
functions pairs acquired during the activities aimed at testing the ability
to reveal ChBF variations (Fig. 6). For each pair, the Δτ0.5 recorded
before the overpressure (BðiÞ, i ∈ ½1; : : : ;5) is drawn with a circle (◯),
whereas the Δτ0.5 recorded during the overpressure (DðiÞ, i ∈ ½1; : : : ; 5)
is drawn with a square (□).
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3.3 Moderate Temperature Increase
The second activity investigates the temperature rise consequent
to TTT laser treatment.
The treatment settings are reported in Table 1.
At the end of the treatment, the ophthalmologist reported
inappreciable visible alterations of the ocular fundus tissues.
Figure 9 shows the obtained autocorrelation functions.
According to Sec. 2.3, the acquired measurements have been
investigated both in terms of characteristic decay times τ0.5
[see Eq. (2)] and percentage variations Δτ0.5 [see Eq. (4)] [no
smooth function has been performed on the recoded g1ðτÞ func-
tions]. The obtained τ0.5 and Δτ0.5 are shown in Figs. 10 and 11,
respectively.
3.4 Injection of Au-Nanoparticles
Finally, the ability to detect nano- and micro-aggregates carried
by the ocular blood flow has been tested by injecting a bolus of
Au-NPs in the ear vein of a rabbit. Data about the injected Au-
NPs bolus are reported in Table 2.
Figure 12 shows the obtained autocorrelation functions.
According to Sec. 2.3, the acquired measurements have been
investigated both in terms of characteristic decay times τ0.5
[see Eq. (2)] and percentage variations Δτ0.5 [see Eq. (4)] [no
smooth function has been performed on the recoded g1ðτÞ func-
tions]. The obtained τ0.5 and Δτ0.5 are shown in Figs. 13 and 14,
respectively.
Fig. 9 Autocorrelation functions acquired during the activities aimed at
testing the ability to reveal fundus temperature variations. The measure-
ment acquired before the TTT treatment is drawn in continuous line
(—), the measurements acquired during the treatment are drawn in
dashed line (– – –) and, the measurements acquired after the TTT
are drawn in bold continuous line (—). The horizontal dashed-dot line
(– . – . –) indicates the g1ðτÞ ¼ 0.5 condition of Eq. (2).
Fig. 10 Characteristic decay times τ0.5 relative to the autocorrelation
functions acquired during the activities aimed at testing the ability to
reveal fundus temperature variations (Fig. 9). The τ0.5 recorded before
the laser treatment (Bð1Þ) is drawn with a circle (◯), the τ0.5 recorded
during the treatment (Dð1Þ ÷ Dð3Þ) are drawn with squares (□), and the
τ0.5 recorded after the treatment (Að1Þ ÷ Að5Þ) are drawn with diamonds
(⋄). The wide rectangle in the background (pink in color version) indi-
cates the TTT treatment.
Fig. 11 Percentage variation Δτ0.5 relative to the autocorrelation func-
tions acquired during the activities aimed at testing the ability to reveal
fundus temperature variations (Fig. 9). The baseline Δτ0.5 recorded
before the laser treatment (Bð1Þ) is drawn with a circle (◯), the Δτ0.5
recorded during the treatment (Dð1Þ ÷ Dð3Þ) are drawn with squares (□),
and the Δτ0.5 recorded after the treatment (Að1Þ ÷ Að5Þ) are drawn with
diamonds (⋄). The wide rectangle in the background (pink in color
version) indicates the TTT treatment.
Fig. 12 Autocorrelation functions acquired during the activities aimed
at testing the ability to detect nano- and micro-aggregate in ocular fun-
dus circulation. The measurements acquired before the injection are
drawn in continuous line (—), the measurements acquired during the
injection are drawn in dashed line (– – –) and, the measurements
acquired after the injection are drawn in bold continuous line (—).
The horizontal dashed-dot line (– . – . –) indicates the g1ðτÞ ¼ 0.5 con-
dition of Eq. (2).
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4 Discussion and Conclusions
Despite the simplicity of the performed data analyses, the
reported results demonstrate the applicability of DCS to ocular
fundus optical inspection. According to our previous articles,4–6
specific theoretical models allow obtaining more information
and distinguishing the contribution of the different fundus layers
(retina, RPE, and choroids). Nevertheless, the proposed simpli-
fied data analysis methods have been able to clearly and easily
demonstrate the DCS ability to analyze variations in physiologi-
cal quantities of clinical interest. Indeed, even though the ocular
fundus is known to be a complex scattering and absorbing
medium,13 and albeit neither single-scattering regime nor multi-
ple-scattering regime are applicable,4,6 DCS has been shown to
be able to: (a) reveal variations in ChBF, (b) disclose variations
in fundus temperature, and (c) detect nano- micro-aggregates
carried by the blood flow in the ocular fundus.
In the following subsections a detailed analysis of the
obtained results is reported.
4.1 Discussion on the Measurement Uncertainty
As reported in Sec. 3.1, the recorded percentage experimental
standard deviations of the sample σ% were essentially less
than 8%. Therefore, by introducing a sort of “safety factor,” the
measurement uncertainty can be roughly estimated in about
10% (both for τ0.5 and Δτ0.5 estimations, see Sec. 2.4).
Obviously, such 10% measurement uncertainty is not the
measurement uncertainty relative to the analysis of blood flow,
temperature variations or NPs, but the measurement uncertainty
relative to τ0.5 and Δτ0.5 estimations. As a result, the measure-
ment uncertainty relative to the analysis of blood flow, temper-
ature variations or NPs is reasonably higher than 10% and
depends on the model used to joint such quantities—blood
flow, temperature, and NPs—to the estimated τ0.5 or Δτ0.5.
Actually, measurement uncertainty depends on both “intrin-
sic” factors such as the developed measurement procedure and
measuring system and “extrinsic” factors relative to the environ-
mental conditions, the investigated animal and the ophthalmolo-
gist that performs the measurements.
For instance, any relative motion between the measuring sys-
tem and the measurand—the rabbit’s eye—results both in an
apparent variation of hΔr2ðτÞi and a possible variation of the
measuring site. Therefore, “extrinsic” factors such as move-
ments of the investigated animal, i.e., due to different response
to the sedatives and slight tremors of the ophthalmologist alter
the measures, thus increasing the measurement uncertainty and
possibly leading to measurement artefacts.
As an example, as previously stated tmeas > 110 ÷ 120 s rap-
idly increases the measurement uncertainty. As shown in Fig. 2
the animal under test was immobilized by using a guillotine sys-
tem and the GLC was hand-held by the ophthalmologist, thus
such measurement uncertainty increase is reasonably an “extrin-
sic” factors depending on rabbit’s and/or ophthalmologist’s
movements. Mechanical tools such as a stereotaxic head-holder
can probably reduce rabbit’s movements; however, for human
testing, such solutions are in general not suitable and a fixation
target is usually the only mechanical tool exploited to prevent
eye movements. Therefore, in order to reduce the effects of such
extrinsic factor—relative motion between the measuring system
and the measurand—we are now working on a mechanical sys-
tem aimed at holding the GLC. Nevertheless, extrinsic factors
can be reduced but obviously not eliminated.
From what has been said previously, the ultimate measure-
ment uncertainty depends on both “intrinsic” factors such as the
measurement procedure, the measuring system and the per-
formed data analysis and “extrinsic” factors relative to the inves-
tigated measurand—animal model or patient—and/or the
ophthalmologist. Therefore, the question whether the “ultimate”
measurement uncertainty level of this system is sufficiently
small to enable clinical applications is beyond the scope of
this article.
Fig. 13 Characteristic decay times τ0.5 relative to the autocorrelation
functions acquired during the activities aimed at testing the ability to
detect nano- and micro-aggregate in ocular fundus circulation (Fig. 12).
The τ0.5 recorded before the nanoparticles (NPs) injection (Bð1Þ ÷ Bð4Þ)
are drawn with circles (◯), the τ0.5 recorded during the injection
(Dð1Þ ÷ Dð2Þ) are drawn with squares (□), and the τ0.5 recorded after
the injection (Að1Þ ÷ Að10Þ) are drawn with diamonds (⋄). The wide rec-
tangle in the background (pink in color version) indicates the NPs
injection.
Fig. 14 Percentage variation Δτ0.5 relative to the autocorrelation func-
tions acquired during the activities aimed at testing the ability to detect
nano- and micro-aggregate in ocular fundus circulation (Fig. 12). The
baseline Δτ0.5 recorded before the NPs injection (Bð1Þ ÷ Bð4Þ) are drawn
with circles (◯), theΔτ0.5 recorded during the injection (Dð1Þ ÷ Dð2Þ) are
drawn with squares (□), and the Δτ0.5 recorded after the injection
(Að1Þ ÷ Að10Þ) are drawn with diamonds (⋄). The wide rectangle in
the background (pink in color version) indicates the NPs injection.
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4.2 Discussion on the Analysis of the Variation of the
Choroidal Blood Flow
The relation between IOP and ChBF has been investigated for a
long time. Although preliminary animal experiments reported
linear relationship, thus neglecting autoregulation, some autor-
egulation has been now demonstrated both in animal experi-
ments46–49 and human testing.50–52
The ChBF regulation is known to be complex and to vary
from subject to subject52 and the performed “handmade” pres-
sure manipulation did not allow estimation of the induced IOP
variation, thus it is difficult to estimate the induced blood flow
variation. Nevertheless, in accordance with the expected ChBF
reduction,46–52 the observed Δτ0.5 (Fig. 8) are significantly
higher than the estimated 10% measurement uncertainty, thus
confirming that the developed measuring system is able to detect
ChBF variations.
Blood flow reduction results in a reduction of the hΔr2ðτÞi
relative to “dynamic” scatterers—scatterers carried by the blood
flow—thus according to Eq. (1), it is expected to result in an
increased “characteristic” decay time τ0.5. Figures 6 and 7
clearly show that DCS is able to detect this phenomenon origi-
nated by an increased IOP.
The large variations shown in Figs. 6 and 7 are not surprising.
According to the study performed by Kiel and Heuven on New
Zealand albino rabbits,47 an increase of the IOP from 10 mmHg
to 100 mmHg can reduce by a factor of 10 the ChBF and
similar results have been obtained analyzing Long-Evan rats.53
Actually, ChBF reduction is due to both blood volume and
velocity reductions. However, according to a recent study per-
formed by Zhi et al. on Brown Norway rats,54 from 10 to
50 mmHg, choroidal blood volume does not change, and at
60, 70, 80, and 100 mmHg, the choroidal blood volume, respec-
tively, reduces of about 6.5%, 15%, 30%, and 80% of baseline.
Therefore, up to 70 mmHg, choroidal blood volume basically
does not change, whereas ChBF can be reduced by about seven
times.47 Since the examined retinal sites were chosen far away
from visible retinal vessels, it means that up to about 70 mmHg,
the IOP increase substantially influenced the movements of
“dynamic” scatterers only, whereas optical properties basically
did not change. Hence, by modeling the ChBF as random
flow—hΔr2ðτÞi ¼ hV2iτ2—and roughly supposing a linear
relationship between ChBF and square root of the mean square
velocity hV2i—ChBF ∝ hV2i1∕2—if ChBF reduces by a factor
of 4 ÷ 7 (i.e., approximately 40 ÷ 70 mmHg), then hΔr2ðτÞi
reduces by a factor of about 16 ÷ 49. Such decorrelation sta-
tistically occurs at each scattering event with dynamic scatterers,
thus leading to high responsivity.
Differences between the results (τ0.5 and Δτ0.5) obtained
under different overpressure conditions are reasonably due to
the poor repeatability of the performed handmade overpressures.
Moreover, measurements may have been collected from slightly
different fundus sites, thus also differences among the investi-
gated regions may be responsible of the differences between the
obtained decay times.
4.3 Discussion on the Analysis of the Variations of
the Fundus Temperature
According to Ibarra et al.,45 the performed 200 mW TTT treat-
ment (see Table 1) is expected to produce a fundus temperature
rise lower than 2°C, whereas the threshold power settings for
visible lesions in albino rabbits is about 950 mW (810 nm
laser diode, spot-size 0.8 mm and, treatment duration 60 s), cor-
responding to retinal temperature increases of about 12°C.45
Change in optical properties of the tissue—whitening—due
to photocoagulation, corresponds to a denaturation of tissue pro-
teins that occurs at approximately 18°C above basal temperature
(i.e., 55°C). Nevertheless, protein denaturation is known to start
under the photocoagulation threshold with a change in the
folding of proteins starting at about 6 ÷ 12°C above basal tem-
perature.55 Despite the gentle laser treatment, the developed
measuring system has been shown able to detect the consequent
moderate temperature increase. The Δτ0.5 variations recorded as
a function of the applied stimulus have been about three times
higher than the estimated measurement uncertainty. Actually,
temperature rising means increased thermal agitation, hence
increased hΔr2ðτÞi of “semi-static” scatterers. According to
Eq. (1), an increased hΔr2ðτÞi is expected to result in a τ0.5
reduction. Indeed, Figs. 9 and 10 show a τ0.5 reduction as a con-
sequence of the gentle TTT treatment. The incomplete baseline
recovery could be due to the temporary and/or permanently
changes in protein conformations during TTT reported by
Mainster and Reichel56 and/or layered structure developing
with a static layer. The analysis of such phenomena can be prob-
ably easily performed by using the two-cells model reported in
our previous articles.4–6
Actually, the τ0.5 reduction agrees with both an increased
thermal motion and a physiologically increased blood flow
aimed at dissipating the excess heat due to the TTT treatment.
As reported in Sec. 2.4, the explored retinal region was chosen
far away from visible vessels. Nevertheless, temperature-
induced vasodynamics of choroids is known to be complex
mechanism.57 Indeed, in 1991, a human study from Parver58
reported that ChBF increases as a consequence of the fundus
heating, whereas a more recent human study from Nagaoka
and Yoshida59 in 2004 reported that ChBF decreases upon heat-
ing of the eye. Supposing that ChBF decreases upon heating of
the eye, the observed τ0.5 reduction is therefore reasonably due
to an increased thermal motion.
Actually, the small ChBF reduction reported by Nagaoka and
Yoshida59 was due to both reduced RBC velocity and reduced
blood volume almost in equal measure. According to Eq. (1),
reduced RBC velocity is expected to results in a hΔr2ðτÞi reduc-
tion, hence increasing τ0.5. On the contrary, reduced blood vol-
ume is expected to result in a reduction in the absorption
coefficient, hence resulting in an increased mean path length s
and thus leading to a reduced τ0.5 (see Sec. 4.4). Therefore, such
thermally induced ChBF reduction is expected to give rise
to two phenomena that roughly compensate each other. As a
result, the τ0.5 and Δτ0.5 reductions shown in Figs. 10 and 11
reasonably confirm the ability to detect variations of the fundus
temperature.
4.4 Discussion on the Detection of Nano- and
Micro-aggregates
Nano- and micro-aggregates carried by the blood flow are
expected to change the fundus optical properties (μa and μs),
thus potentially changing PðsÞ, hq2i and, ls. On the contrary,
being the aggregates carried by the blood flow, no change is
expected with respect to the hΔr2ðτÞi relative to the blood
flow itself (“dynamic” scatterers).
As shown in Figs. 12 and 13, DCS is able to detect the
Au-NPs transit and the subsequent physiological recovery.
The obtained results are in accordance with the Au-NPs optical
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properties reported in a theoretical study by Jain et al.60
According to Jain et al.,60 the injected Au-NPs have
μs∕μa ≪ 1, therefore the probability that photons have to be
scattered by Au-NPs is extremely low. Moreover, Au-NPs
have higher absorption compared to RBCs.60 Hence, also con-
sidering the small injected volume (Table 2), Au-NPs injection
roughly affects PðsÞ only. Since the absorption coefficient μa
describes the mean distance la ¼ 1∕μa traveled by a photon
before it is statistically absorbed, the higher the absorption coef-
ficient and the lower the probability of long-path photons to be
detected. Therefore, roughly supposing hq2i, ls and hΔr2ðτÞi to
be the same all over the volume under test, from Eq. (1) it is easy
to notice that a reduction in the path length s results in a reduc-
tion of the s∕ls ratio, hence resulting in an increase of the char-
acteristic decay time τ0.5.
In agreement with the theoretical expectations, Figs. 12 and
13 show an abrupt increase in the τ0.5 as a consequence of the
NPs injection. Then, the τ0.5 gradually returns to baseline during
the physiological recovery.
Actually, both the effects due to: (a) the saline solution opti-
cal properties and, (b) the potential transient changes in blood
pressure during the injection may have contributed to the τ0.5
variations. However, physiological saline solution has optical
properties similar to pure water,61 thus negligible absorption
compared to blood. As a result, physiological saline solution
is expected to result in a (tiny) μa reduction, thus to result in a
(tiny) increase in the path length s hence, to result in a (tiny)
reduction of the characteristic decay time τ0.5.
On the other side, accordingly to the discussion and the refer-
ences reported in Sec. 4.2, i.e., Kiel et al.,46–49 there is clearer
evidence of autoregulation in the rabbit’s choroid. The per-
formed NPs injection had a mean flow of about 0.02 ml∕s
(see Table 2), thus it is reasonable to suppose it to lead to limited
changes in blood pressure, hence leading to little or no effect on
ChBF and volume. Moreover, it is reasonable to suppose the
recovery time due to changes in blood pressure to be faster
than the ≈45 s shown in Figs. 13 and 14.46 Therefore, the results
shown in Figs. 12–14 are reasonably due to nano- and micro-
aggregates, thus confirming the ability to detect nano- and
micro-aggregates.
4.5 Discussion on the Data Analysis
The question of which data analysis method is more appropriate
for a specific task is quite difficult to address.
As previously discussed, the proposed simplified data analy-
sis method is not intended to replace the previous specialized
data analysis methods4–6 and new different data analysis meth-
ods may provide better performances and/or even simpler analy-
sis. Actually, specific theoretical models allow obtaining more
information and may be necessary for some particular applica-
tions. Nevertheless, to fully access the information offered by
the data analysis methods so far proposed in the literature,4,6
additional data such as μa, μs and, the α and β probabilities
4
are required.
Regardless of the specific clinical situation, the more suitable
data analysis method is probably the simpler one able to provide
a measurement uncertainty lower or equal to the target mea-
surement uncertainty—measurement uncertainty specified as
an upper limit and decided on the basis of the intended use of
measurement results.62 Unfortunately, as discussed in Sec. 4.1,
measurement uncertainty depends on both “intrinsic” and
“extrinsic” factors, thus resulting in extremely difficult to
estimate. Nevertheless, the combined standard measurement
uncertainty is reasonably greater than the individual standard
measurement uncertainties associated with the input quantities
in the measurement model,63 thus some comparisons can be
made based on the data available for the analysis—the input
quantities.
The simplified analytical distribution form (SADF) proposed
in our first article,4 supposes single-path in order to model the
complicated photon path distribution in ocular fundus. In
order to do so, it is necessary to know the thickness and the
optical properties of the investigated ocular fundus layers. The
higher the uncertainties in thickness and/or optical properties,
the higher the uncertainty relative to the single-path SADF
model. Therefore, the single-path SADF data analysis method
can be useful when the thickness and the optical properties
are known, whereas resulting less applicable when such quan-
tities are less known. As an example, the coefficients used in the
previous SADF4 were relative to pigmented rabbits ocular fun-
dus, thus such model can not be directly applied for the analysis
of albino rabbits.
The second data analysis method6 performs the inversion of
the Laplace equation by using the CONTIN software, hence
reasonably allowing to highly reduce the issues relative to
the uncertainties in thickness and/or optical properties. How-
ever, CONTIN software is time-consuming, thus resulting less
appealing for real-time analysis. Moreover, the severe nonortho-
gonality of exponentials leads to an ill-conditioned problem,
hence the inversion of the Laplace integral suffers from the
following problems:64 (a) distortion in the g2ðτÞ function due to
nonideal experimental conditions such as baseline errors and
nonuniform laser beam profile, (b) noise that do not exhibit the
nature of exponential decay, and (c) limited delay-times range of
correlators. As a result, the data analysis method based on the
inversion of the Laplace integral requires accurate system design
in order to avoid distortion in the g2ðτÞ function and practically
results less appealing for real-time analysis or the analysis of
noisy datasets.
The proposed simplified data analysis methods—Eqs. (2)
and (4), τ0.5 and Δτ0.5—offer extremely easy interpretation of
the experimental data and allow fluent implementation of
real-time analysis. As an example, this is a clear advantage for
all applications aimed at the definition of an end-point.
Moreover, they neither relay on the knowledge of anatomical
data nor perform the inversion of the Laplace integral, hence
realistically resulting less sensitive to both (a) uncertainties in
the thickness and the optical properties of the investigated ocular
fundus and (b) nonideal experimental conditions and noises.
Actually, according to the reported results the τ0.5 analysis
seems to be more sensitive to inter- and intra-individual variabil-
ity than the Δτ0.5 analysis. As a matter of fact, the τBASE values
reported in Figs. 4, 7, 10, and 13 range from≈20 to≈100 μs. On
the contrary, the Δτ0.5 analysis seems to be robust to inter- and
intra-individual variability. Indeed, the Δτ0.5 variations recorded
as a function of the applied stimulus have been always greater
than the measurement uncertainty, thus potentially allowing to
quantify the magnitude of each fundus variation—ChBF, tem-
perature and nano- and micro-particles.
4.6 Comparison with Other Measurement
Techniques
As previously stated, DCS and Laser Doppler systems are
based on the same physical principle and offer the advantage
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to provide noninvasive measurements of blood flow. However,
Laser Doppler systems are based on confocal configurations,
thus the volume probed by the detected photons is accordingly
small. Moreover, single photon counting approach of DCS
offers better performance in terms of sensitivity, hence allowing
to better investigate the feeble signal arising from multiple-
scattering.
Among ancillary tests in ophthalmic practice, OCT is prob-
ably the most commonly used. The OCT is a noncontact and
noninvasive imaging technique widely used for human eye im-
aging.65 The use of OCT in ophthalmology is not limited to a
“static” analysis. As an example, when OCT is combined with
Doppler analysis, it can be used to measure retinal blood flow,66
and optical microangiography (OMAG) is capable of generating
3D dynamic perfusion images of tissue microcirculation.67 Joint
spectral and time domain optical coherence tomography (joint
STdOCT) has been shown capable of three-dimensional quan-
titative imaging of retinal and ChBF,68 and D-OMAG used
in conjunction with and ultrahigh sensitive OMAG (UHS-
OMAG) allows to obtain simultaneous 3D angiography and
quantitative retinal blood flow measurement.69
Moreover, OCT can be used to access TTT treatments out-
come, i.e., as in Refs. 70 and 71. However, there is a latency in
tissue denaturation after the laser is stopped55 and this is prob-
ably one of the reasons why, to the best of our knowledge, there
were no study reports about the use of OCT for determining an
endpoint for TTT treatments.
On the contrary, the use of OCT for monitoring of NPs in
biological tissues has been reported.72,73
However, OCT systems are extremely complex systems
based on a low coherence interferometer. As an example, in
Time domain OCT the sample is scanned by changing the path-
length in the reference arm and the position of the measurement
beam on the sample, respectively. Therefore: (a) the pathlength
in the reference arm has to be scanned rapidly and precisely, (b)
the amplitude of such pathlength variation must be large enough
to cover the desired axial imaging range—the depth of volume
under test—and (c) the position of the measurement beam has to
be moved rapidly and precisely all over the volume under test
ensuring appropriate focus, thus requiring complex scanning
mechanisms. Then, the OCT image is composed by analyzing
all the signals recorded for each reference arm pathlength and
measurement arm position. Frequency domain OCT allows to
avoid to change the pathlength in the reference arm, but it
requires the use of a spectrometer for the analysis of the col-
lected signal. Therefore, OCT systems require expensive optical
and electronic components and complex software, hence result-
ing expensive systems.
On the contrary, in DCS systems, there are neither reference
arms nor the scanning mechanisms and the dimension and the
depth of the volume under test is simply determined by the dis-
tance between the illumination spot and the collection point. As
a result, the integration of DCS system with OMs is easy and
less expensive. As a matter of fact, the proposed DCS system
has been integrated by simply using a beam splitter (Sec. 2.2)
and the DCS system cost—excluding the OM—is about 10,000
dollars.
4.7 Conclusions
From the discussion above, it is clear that the definition of the
achievable metrological performances, i.e., responsivity and
limit of detection, depends on several “intrinsic” and “extrinsic”
factors. Therefore, there are currently no guarantees that the
developed measuring system can definitely contribute in under-
standing and/or improving the current clinical issues and much
more work will be needed before the proposed measuring sys-
tem will reach clinical maturity. However, the reported results
suggest that important diagnostic information can be obtained
from DCS measurements of the ocular fundus.
The ability to detect ChBF variations can be useful both in
fundamental research and practical clinical applications. Indeed,
even though the ability to detect ChBF variations has been tested
by increasing IOP, the system capability to reveal ChBF varia-
tions is reasonably not limited to the analysis of perturbations
induced by pressure variations.
The ability to detect variations in the fundus temperature can
be useful in managing TTT, PDT, and DEP, thus allowing to
avoid or reduce treatment complications.
The ability to detect nano- and micro-aggregate could allow
both diagnoses when the presence of such aggregates is related
to specific diseases, i.e., diseases related to the environmental
pollution and verifying for instance the impact of NPs injection
in nanomedicine. Moreover, the state of aggregation of the NPs
affects their optical properties, hence in general affecting PðsÞ,
hq2i, and ls. As a result, DCS also theoretically allows inves-
tigation of variations in the state of aggregation of the flowing
NPs. However, the proposed data analysis do not allow to differ-
entiate between g1ðτÞ variations due to variations in NPs con-
centration or state of aggregation. As a result, the NPs state
of aggregation can be investigated only if the NPs concentration
inside the sample is known or it does not change among the
various measurements.
Finally, Au-NPs are not only a suitable test to investigate the
ability to detect nano- and micro-aggregates in blood cir-
culation, but also a good option for DPE. According to Jain
et al.,60 the Au-NPs shape and dimension can be tailored in
order to obtain the desired absorption and scattering spectra,
thus resulting in a suitable dye for DEP. Nevertheless, DCS is
theoretically able to detect any dye that affects any of PðsÞ, hq2i,
and ls. Therefore, no restriction is theoretically imposed on dye
selection for DEP.
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